Cargando…
C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
BACKGROUND: Laryngeal cancer tends to have a very poor prognosis due to the unsatisfactory efficacy of chemotherapy for this cancer. Multidrug resistance (MDR) is the main cause of chemotherapy failure. The proto-oncogene c-fos has been shown to be involved in the development of MDR in several tumor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819209/ https://www.ncbi.nlm.nih.gov/pubmed/29483928 http://dx.doi.org/10.1186/s11658-017-0067-8 |
_version_ | 1783301166249017344 |
---|---|
author | Li, Guodong Hu, Xiaoling Sun, Lu Li, Xin Li, Jianfeng Li, Tongli Zhang, Xiaohui |
author_facet | Li, Guodong Hu, Xiaoling Sun, Lu Li, Xin Li, Jianfeng Li, Tongli Zhang, Xiaohui |
author_sort | Li, Guodong |
collection | PubMed |
description | BACKGROUND: Laryngeal cancer tends to have a very poor prognosis due to the unsatisfactory efficacy of chemotherapy for this cancer. Multidrug resistance (MDR) is the main cause of chemotherapy failure. The proto-oncogene c-fos has been shown to be involved in the development of MDR in several tumor types, but few studies have evaluated the relationship between c-fos and MDR in laryngeal cancer. We investigated the role of c-fos in MDR development in laryngeal cancer cells (cell line: human epithelial type 2, HEp-2) using the chemotherapeutic vincristine (VCR). METHODS: HEp-2/VCR drug resistance was established by selection against an increasing drug concentration gradient. The expressions of c-fos and multidrug resistance 1 (mdr1) were measured using qPCR and western blot. C-fos overexpression or knockdown was performed in various cells. The intracellular rhodamine-123 (Rh-123) accumulation assay was used to detect the transport capacity of P-glycoprotein (P-gp, which is encoded by the mdr1 gene). RESULTS: HEp-2 cells with VCR-induced resistance (HEp-2/VCR cells) were not only resistant to VCR but also evolved cross-resistance to other chemotherapeutic drugs. The expressions of the c-fos and mdr1genes were significantly higher in the HEp-2/VCR cells than in control cells. C-fos overexpression in HEp-2 cells (c-fos WT) resulted in increased P-gp expression and increased the IC(50) for 5-FU. C-fos knockdown in the HEp-2/VCR cells (c-fos shRNA) resulted in decreased P-gp expression and decreased IC(50) for 5-FU. An intracellular Rh-123 accumulation assay showed that the mean intracellular fluorescence intensity (MFI) was lower in the HEp-2/VCR cells than in HEp-2 cells. C-fos WT cells also showed lower MFI. By contrast, c-fos shRNA cells exhibited a higher MFI than the control group. CONCLUSION: C-fos increased the expression of P-gp and mdr1 in the HEp-2/VCR cells, and enhanced the efflux function of the cells, thereby contributing to the development of MDR. |
format | Online Article Text |
id | pubmed-5819209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58192092018-02-26 C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance Li, Guodong Hu, Xiaoling Sun, Lu Li, Xin Li, Jianfeng Li, Tongli Zhang, Xiaohui Cell Mol Biol Lett Research BACKGROUND: Laryngeal cancer tends to have a very poor prognosis due to the unsatisfactory efficacy of chemotherapy for this cancer. Multidrug resistance (MDR) is the main cause of chemotherapy failure. The proto-oncogene c-fos has been shown to be involved in the development of MDR in several tumor types, but few studies have evaluated the relationship between c-fos and MDR in laryngeal cancer. We investigated the role of c-fos in MDR development in laryngeal cancer cells (cell line: human epithelial type 2, HEp-2) using the chemotherapeutic vincristine (VCR). METHODS: HEp-2/VCR drug resistance was established by selection against an increasing drug concentration gradient. The expressions of c-fos and multidrug resistance 1 (mdr1) were measured using qPCR and western blot. C-fos overexpression or knockdown was performed in various cells. The intracellular rhodamine-123 (Rh-123) accumulation assay was used to detect the transport capacity of P-glycoprotein (P-gp, which is encoded by the mdr1 gene). RESULTS: HEp-2 cells with VCR-induced resistance (HEp-2/VCR cells) were not only resistant to VCR but also evolved cross-resistance to other chemotherapeutic drugs. The expressions of the c-fos and mdr1genes were significantly higher in the HEp-2/VCR cells than in control cells. C-fos overexpression in HEp-2 cells (c-fos WT) resulted in increased P-gp expression and increased the IC(50) for 5-FU. C-fos knockdown in the HEp-2/VCR cells (c-fos shRNA) resulted in decreased P-gp expression and decreased IC(50) for 5-FU. An intracellular Rh-123 accumulation assay showed that the mean intracellular fluorescence intensity (MFI) was lower in the HEp-2/VCR cells than in HEp-2 cells. C-fos WT cells also showed lower MFI. By contrast, c-fos shRNA cells exhibited a higher MFI than the control group. CONCLUSION: C-fos increased the expression of P-gp and mdr1 in the HEp-2/VCR cells, and enhanced the efflux function of the cells, thereby contributing to the development of MDR. BioMed Central 2018-02-20 /pmc/articles/PMC5819209/ /pubmed/29483928 http://dx.doi.org/10.1186/s11658-017-0067-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Li, Guodong Hu, Xiaoling Sun, Lu Li, Xin Li, Jianfeng Li, Tongli Zhang, Xiaohui C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance |
title | C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance |
title_full | C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance |
title_fullStr | C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance |
title_full_unstemmed | C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance |
title_short | C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance |
title_sort | c-fos upregulates p-glycoprotein, contributing to the development of multidrug resistance in hep-2 laryngeal cancer cells with vcr-induced resistance |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819209/ https://www.ncbi.nlm.nih.gov/pubmed/29483928 http://dx.doi.org/10.1186/s11658-017-0067-8 |
work_keys_str_mv | AT liguodong cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance AT huxiaoling cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance AT sunlu cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance AT lixin cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance AT lijianfeng cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance AT litongli cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance AT zhangxiaohui cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance |